FibroGen, Inc. (FGEN)
NASDAQ: FGEN · IEX Real-Time Price · USD
1.170
-0.100 (-7.87%)
At close: Apr 18, 2024, 4:00 PM
1.200
+0.030 (2.56%)
After-hours: Apr 18, 2024, 6:39 PM EDT
FibroGen Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for FibroGen stock have an average target of 5.00, with a low estimate of 2.00 and a high estimate of 11. The average target predicts an increase of 327.35% from the current stock price of 1.17.
Analyst Consensus: Sell
* Price targets were last updated on Aug 8, 2023.
Analyst Ratings
The average analyst rating for FibroGen stock from 5 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 | 4 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 6 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Hold → Sell Downgrades $4 → $2 | Hold → Sell | Downgrades | $4 → $2 | +70.94% | Aug 8, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $16 → $2 | Strong Sell | Maintains | $16 → $2 | +70.94% | Jun 27, 2023 |
| Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 27, 2023 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $29 → $4 | Strong Buy → Hold | Downgrades | $29 → $4 | +241.88% | Jun 26, 2023 |
| Stifel | Stifel | Strong Buy → Hold Downgrades $28 → $11 | Strong Buy → Hold | Downgrades | $28 → $11 | +840.17% | Jun 26, 2023 |
Financial Forecast
Revenue This Year
161.52M
from 147.75M
Increased by 9.32%
Revenue Next Year
172.83M
from 161.52M
Increased by 7.00%
EPS This Year
-1.32
from -2.92
EPS Next Year
-0.44
from -1.32
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 180.6M | 205.8M | 218.3M | 242.6M | 264.6M |
| Avg | 161.5M | 172.8M | 209.1M | 235.6M | 257.0M |
| Low | 142.0M | 144.1M | 198.0M | 226.4M | 247.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 22.2% | 27.4% | 26.3% | 16.0% | 12.3% |
| Avg | 9.3% | 7.0% | 21.0% | 12.7% | 9.1% |
| Low | -3.9% | -10.8% | 14.5% | 8.3% | 4.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.08 | 0.72 | 1.11 | -0.26 | 0.04 |
| Avg | -1.32 | -0.44 | 0.12 | -0.26 | 0.04 |
| Low | -1.67 | -1.15 | -0.81 | -0.25 | 0.04 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.